Construction of miR-15-a-loaded nano-complex and evaluation of its anti-prostate cancer effect in vitro
- Author:
Zhao-Yong WU
1
Author Information
- Publication Type:Journal Article
- Keywords: MiR-15-a; Polycationic carrier; Prostate cancer
- From: Chinese Pharmaceutical Journal 2017;52(3):206-211
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To synthesize cationic polymers of arginine-histidine (HRss) based on disulfide crosslink and construct novel nano-complex HRss/miR-15-a, then study its anti-prostate cancer effect in vitro. METHODS: 1H-NMR was used to characterize HRss2/miR-15-a. Zeta sizer was adopted to estimate the Zeta potential and particle size of the nano-complex. Gel electrophoresis was employed to determine the condensation capacity of HRssto miR-15-a. The cytotoxicity and transfection efficiency of HRss was evaluated using prostate cancer stem-like cells (RC-92a/hTERT). Transwell chambers were used to evaluate the influence of HRss/miR-15-a against the motility of RC-92a/hTERT. RESULTS: The RESULTS of cytotoxicity tests indicated that the carrier HRss2 had low toxicity in both normal cells and cancer cells, and the miR-15-a could be loaded in HRss2 to form stable nano-complex. The transfection efficiency and inhibited motility of HRss2/miR-15-a against RC-92a/hTERT were statistically higher than those of HRss1/miR-15-a and HRss3/miR-15-a. CONCLUSION: HRss may be useful for gene delivery, and HRss2, as the optimum polycationic carrier as shown by in vitro evaluation, has the potential to become a novel gene vector in the therapy of prostate cancer.
